メンタルヘルスの臨床試験の世界市場規模調査＆予測、フェーズ別、試験デザイン別、スポンサー別、疾患別、地域別分析、2022-2029年

メンタルヘルスの問題を扱うクリニックです。

予測期間を通じて、メンタルヘルス臨床試験の世界市場は大きく拡大すると予測されています。精神疾患の発生率、精神疾患に対する社会の認識、政府機関、企業、病院、大学からの資金提供の増加が、市場拡大を促す主な理由となっています。さらに、精神疾患の患者数の増加や、主要な市場関係者による取り組みが、予測期間中に市場に有利な成長機会を生み出しています。

精神疾患は、思考、行動、感情のコントロールに大きな支障をきたすことが特徴です。WHOの最新報告によると、2022年には世界の8人に1人が精神疾患に罹患するとされています。最も一般的な2つの精神疾患である悲しみと不安は、2019年に世界で9億7,000万人に影響を与えました。心配、過度の恐怖、およびそれに伴う行動異常は、不安障害の特徴です。2019年WHOの推計によると、3億100万人の不安障害者のうち、5,800万人が子供と青年です。不安障害には、全般性不安障害、パニック障害、社会不安障害など、数多くの種類があります。WHOの科学的分析によると、COVID-19のパンデミックは、世界的に不安と鬱の有病率を25％増加させたとされています。パンデミックの社会的孤立によってもたらされたストレスが大きな要因となっています。うつ病や不安は、病気や痛み、孤独、お金の心配、喪失後の弔いなど、さまざまな恐怖によって引き起こされます。しかし、メンタルヘルス臨床試験のコストが高いため、2022-2029年の予測期間を通じて市場の成長が阻害されています。

メンタルヘルス臨床試験の世界市場調査において考慮された主要地域は、アジア太平洋地域、北米、欧州、中南米、その他世界の地域です。研究開発費の増加、政府の支援政策、臨床試験における革新的技術の使用の増加などの要因から、北米は予測期間を通じて最大の市場シェアを持つと予測されています。Clinicaltrials.orgの報告によると、2019年から2021年にかけて、うつ病の登録臨床試験全体の52％がこの地域で実施されるとされています。また、2019年から2021年にかけて、同地域の治験比率は45.9%から50.9%に上昇するとされています。これに伴い、アジア太平洋は、臨床試験数の増加により、予測期間中に最も速いCAGRで成長しています。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の市場規模を予測することにあります。本レポートは、調査対象国の産業の質的・量的な側面を取り込むよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や市場情勢の詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

• マーケットスナップショット
• 世界・セグメント別市場推定・予測、2019年～2029年
  • メンタルヘルスの臨床試験市場、地域別、2019-2029年
  • メンタルヘルスの臨床試験市場、試験デザイン別、2019-2029年
  • メンタルヘルスの臨床試験市場、スポンサー別、2019-2029年
  • メンタルヘルスの臨床試験市場、疾患別、2019-2029年
• 主な動向
• 調査手法
• 調査の前提条件

第2章 メンタルヘルス臨床試験の世界市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 調査対象範囲
  • 産業の進化
• 本調査の対象となった年
• 通貨換算レート

第3章 世界のメンタルヘルス臨床試験市場力学

• メンタルヘルス臨床試験市場のインパクト分析（2019年～2029年）
  • 市場促進要因
    • 政府からの資金提供の増加
    • 増え続ける臨床試験
  • 市場の課題
    • メンタルヘルスの臨床試験の高いコスト
  • 市場機会
    • 増加する精神疾患の数
    • 市場主要プレーヤー別イニシアティブの高まり

第4章 世界のメンタルヘルス臨床試験市場の産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
• PEST分析
  • 政治的
  • 経済的
  • ソーシャル
  • テクニカル
• 投資採用モデル
• アナリストの提言と結論
• 主な投資機会
• 主要成功戦略

第5章 リスク評価：COVID-19の影響

• COVID-19が業界に与える全体的な影響についての評価
• COVID-19以前とCOVID-19以後の市場シナリオ

第6章 メンタルヘルスの臨床試験の世界市場、フェーズ別

• マーケットスナップショット
• メンタルヘルスの臨床試験の世界市場：フェーズ別、実績別）-ポテンシャル分析
• 世界のメンタルヘルス臨床試験市場のフェーズ別推定・予測2019-2029
• メンタルヘルスの臨床試験市場、サブセグメント分析
  • フェーズi
  • フェーズII
  • フェーズIII
  • フェーズIV

第7章 メンタルヘルスの臨床試験の世界市場、試験デザイン別

• マーケットスナップショット
• メンタルヘルスの臨床試験の世界市場：試験デザイン、実績別- ポテンシャル分析
• 世界のメンタルヘルス臨床試験市場の試験デザイン別推定・予測2019～2029年
• メンタルヘルスの臨床試験市場、サブセグメント分析
  • インターベンション
  • 観察型
  • アクセスの拡大

第8章 メンタルヘルス臨床試験の世界市場、スポンサー別

• マーケットスナップショット
• メンタルヘルスの臨床試験の世界市場：スポンサー別、実績別）-ポテンシャル分析
• 世界のメンタルヘルス臨床試験市場のスポンサー別推定・予測2019-2029
• メンタルヘルスの臨床試験市場、サブセグメント分析
  • 製薬会社・バイオ医薬品会社
  • 政府関係者
  • その他

第9章 メンタルヘルスの臨床試験の世界市場、疾患別

• マーケットスナップショット
• メンタルヘルスの臨床試験の世界市場：疾患別、業績別）-ポテンシャル分析
• 世界のメンタルヘルス臨床試験市場の疾患別推定・予測2019～2029年
• メンタルヘルスの臨床試験市場、サブセグメント分析
  • 不安障害
  • うつ病
  • 双極性感情障害
  • 解離と解離性障害
  • 統合失調症（Schizophrenia
  • その他

第10章 メンタルヘルス臨床試験の世界市場：地域別分析

• メンタルヘルスの臨床試験市場、地域別市場スナップショット
• 北米
  • 米国
    • フェーズ別の推定・予測、2019年～2029年
    • スタディデザイン別の推定・予測、2019年～2029年
    • スポンサー別の推定・予測、2019年～2029年
    • 障害別の推定・予測、2019年～2029年
  • カナダ
• 欧州メンタルヘルス臨床試験市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋のメンタルヘルス臨床試験市場スナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカメンタルヘルス臨床試験市場スナップショット
  • ブラジル
  • メキシコ
• 世界のその他の地域

第11章 競合情報

• トップ市場戦略
• 企業プロファイル
  • ICON Plc.
    • 主要な情報
    • 概要
    • 財務（データの入手が可能な場合のみ）
    • 製品概要
    • 最近の動向
  • Eli Lilly and Company
  • Caidya
  • Syneous Health
  • Novo Nordisk AS
  • Pharmaceutical Product Development, LLC
  • Parexel International Corporation
  • Corcept Therapeutics Incorporated（Corcept）
  • Labcorp Drug Development
  • IQVIA, Inc.

第12章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • バリデーション
  • 出版
• 調査の特徴
• 調査の前提条件

LIST OF TABLES

• TABLE 1. Global Mental Health Clinical Trials Market, report scope
• TABLE 2. Global Mental Health Clinical Trials Market estimates & forecasts by Region 2019-2029 (USD Billion)
• TABLE 3. Global Mental Health Clinical Trials Market estimates & forecasts by Phase 2019-2029 (USD Billion)
• TABLE 4. Global Mental Health Clinical Trials Market estimates & forecasts by Study Design 2019-2029 (USD Billion)
• TABLE 5. Global Mental Health Clinical Trials Market estimates & forecasts by Sponsor 2019-2029 (USD Billion)
• TABLE 6. Global Mental Health Clinical Trials Market estimates & forecasts by Disorder 2019-2029 (USD Billion)
• TABLE 7. Global Mental Health Clinical Trials Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 8. Global Mental Health Clinical Trials Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Global Mental Health Clinical Trials Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 10. Global Mental Health Clinical Trials Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 11. Global Mental Health Clinical Trials Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Global Mental Health Clinical Trials Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 13. Global Mental Health Clinical Trials Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 14. Global Mental Health Clinical Trials Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. Global Mental Health Clinical Trials Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 16. Global Mental Health Clinical Trials Market by region, estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 17. U.S. Mental Health Clinical Trials Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 18. U.S. Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 19. U.S. Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 20. Canada Mental Health Clinical Trials Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 21. Canada Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 22. Canada Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 23. UK Mental Health Clinical Trials Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 24. UK Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 1. UK Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 2. Germany Mental Health Clinical Trials Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 3. Germany Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 4. Germany Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 5. France Mental Health Clinical Trials Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 6. France Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 7. France Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 8. Italy Mental Health Clinical Trials Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 9. Italy Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 10. Italy Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 11. Spain Mental Health Clinical Trials Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 12. Spain Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 13. Spain Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 14. RoE Mental Health Clinical Trials Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 15. RoE Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 16. RoE Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 17. China Mental Health Clinical Trials Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 18. China Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 19. China Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 20. India Mental Health Clinical Trials Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 21. India Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 22. India Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 23. Japan Mental Health Clinical Trials Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 24. Japan Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 25. Japan Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 26. South Korea Mental Health Clinical Trials Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 27. South Korea Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 28. South Korea Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 29. Australia Mental Health Clinical Trials Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 30. Australia Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 31. Australia Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 32. RoAPAC Mental Health Clinical Trials Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 33. RoAPAC Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 34. RoAPAC Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 35. Brazil Mental Health Clinical Trials Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 36. Brazil Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 37. Brazil Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 38. Mexico Mental Health Clinical Trials Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 39. Mexico Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 40. Mexico Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 41. RoLA Mental Health Clinical Trials Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 42. RoLA Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 43. RoLA Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 44. Row Mental Health Clinical Trials Market estimates & forecasts, 2019-2029 (USD Billion)
• TABLE 45. Row Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 46. Row Mental Health Clinical Trials Market estimates & forecasts by segment 2019-2029 (USD Billion)
• TABLE 47. List of secondary sources, used in the study of global Mental Health Clinical Trials Market
• TABLE 48. List of primary sources, used in the study of global Mental Health Clinical Trials Market
• TABLE 49. Years considered for the study
• TABLE 50. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Mental Health Clinical Trials Market, research methodology
• FIG 2. Global Mental Health Clinical Trials Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Mental Health Clinical Trials Market, key trends 2021
• FIG 5. Global Mental Health Clinical Trials Market, growth prospects 2022-2029
• FIG 6. Global Mental Health Clinical Trials Market, porters 5 force model
• FIG 7. Global Mental Health Clinical Trials Market, pest analysis
• FIG 8. Global Mental Health Clinical Trials Market, value chain analysis
• FIG 9. Global Mental Health Clinical Trials Market by segment, 2019 & 2029 (USD Billion)
• FIG 10. Global Mental Health Clinical Trials Market by segment, 2019 & 2029 (USD Billion)
• FIG 11. Global Mental Health Clinical Trials Market by segment, 2019 & 2029 (USD Billion)
• FIG 12. Global Mental Health Clinical Trials Market by segment, 2019 & 2029 (USD Billion)
• FIG 13. Global Mental Health Clinical Trials Market by segment, 2019 & 2029 (USD Billion)
• FIG 14. Global Mental Health Clinical Trials Market, regional snapshot 2019 & 2029
• FIG 15. North America Mental Health Clinical Trials Market 2019 & 2029 (USD Billion)
• FIG 16. Europe Mental Health Clinical Trials Market 2019 & 2029 (USD Billion)
• FIG 17. Asia pacific Mental Health Clinical Trials Market 2019 & 2029 (USD Billion)
• FIG 18. Latin America Mental Health Clinical Trials Market 2019 & 2029 (USD Billion)
• FIG 19. Global Mental Health Clinical Trials Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Mental Health Clinical Trials Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. This are the clinics which deals with mental health problems. Throughout the course of the projection period, it is predicted that the global market for mental health clinical trials would expand significantly. The incidence of mental health illnesses, public awareness of mental health conditions, and increased funding from government agencies, businesses, hospitals, and universities are the main reasons driving the market's expansion. Moreover, rising number of mental illness and initiative by key market players are creating lucrative growth opportunity for the market over the forecast period.

Significant disruptions in thought, behavior, or emotional regulation characterize mental illnesses. According to a recent WHO report, 1 in every 8 people worldwide will have a mental condition in 2022. The two most prevalent mental illnesses, sadness, and anxiety, affected 970 million individuals worldwide in 2019.Worry, excessive fear, and accompanying behavioral abnormalities are hallmarks of anxiety disorders. According to 2019 WHO estimate, 58.0 million of the 301.0 million people with anxiety disorders are children and adolescents. There are numerous varieties of anxiety disorders, including generalized anxiety disorder, panic disorder, and social anxiety disorder. According to a scientific analysis by the WHO, the COVID-19 pandemic increased the prevalence of anxiety and depression globally by 25%. Stress brought on by the pandemic's social isolation is a significant factor. Depression and anxiety are caused by a variety of fears, including those of illness, pain, loneliness, money worries, and mourning following a loss. However, the high cost of Mental Health Clinical Trials stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Mental Health Clinical Trials Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. Due to factors similar to increased R&D spending, supportive government policies, and growth in the use of innovative technologies in clinical trials, North America is predicted to have the largest market share throughout the projection period. Clinicaltrials.org reports that from 2019 to 2021, 52% of all registered clinical trials for depression would be conducted in the region. Also, from 2019 to 2021, the region's trial percentage will rise from 45.9% to 50.9%. Along with this, Asia-Pacific is growing with the fastest CAGR over the forecast period owing to the rising number of clinical trials.

Major market players included in this report are:

• ICON Plc.
• Eli Lilly and Company
• Caidya
• Syneous Health
• Novo Nordisk AS
• Pharmaceutical Product Development, LLC
• Parexel International Corporation
• Corcept Therapeutics Incorporated (Corcept)
• Labcorp Drug Development
• IQVIA, Inc.

Recent Developments in the Market:

• In September 2022, the launch of Epic's Life Sciences division broadens its efforts to reunite the fragmented elements of the healthcare system. The goals of the program is to include facilitating the recruitment of research participants, accelerating the development of novel treatments for providers, and increasing access to clinical trials for underrepresented populations, pharmaceutical firms, and medical device manufacturers.

Global Mental Health Clinical Trials Market Report Scope:

• Historical Data: 2019-2020-2021

• Base Year for Estimation: 2021

• Forecast period: 2022-2029

• Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

• Segments Covered: Study Design, Sponsor, Disorder, Region

• Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

• Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Study Design offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Phase:

• Phase I
• Phase II
• Phase III
• Phase IV

By Study Design:

• Interventional
• Observational
• Expanded Access

By Sponsor:

• Pharmaceutical & Biopharmaceutical Companies
• Government Agencies
• Others

By Disorder:

• Anxiety Disorders
• Depression
• Bipolar affective disorder
• Dissociation and dissociative disorders
• Schizophrenia
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Rest of the World

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  • 1.2.1. Mental Health Clinical Trials Market, by Region, 2019-2029 (USD Billion)
  • 1.2.2. Mental Health Clinical Trials Market, by Study Design, 2019-2029 (USD Billion)
  • 1.2.3. Mental Health Clinical Trials Market, by Sponsor, 2019-2029 (USD Billion)
  • 1.2.4. Mental Health Clinical Trials Market, by Disorder, 2019-2029 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Mental Health Clinical Trials Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Mental Health Clinical Trials Market Dynamics

• 3.1. Mental Health Clinical Trials Market Impact Analysis (2019-2029)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Increasing government funding
    • 3.1.1.2. Growing number of clinical trials
  • 3.1.2. Market Challenges
    • 3.1.2.1. High Cost of Mental Health Clinical Trials
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising number of mental illnesses
    • 3.1.3.2. Rising initiatives by the key market players

Chapter 4. Global Mental Health Clinical Trials Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
• 4.4. Investment Adoption Model
• 4.5. Analyst Recommendation & Conclusion
• 4.6. Top investment opportunity
• 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1. Assessment of the overall impact of COVID-19 on the industry
• 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Mental Health Clinical Trials Market, by Phase

• 6.1. Market Snapshot
• 6.2. Global Mental Health Clinical Trials Market by Phase, Performance - Potential Analysis
• 6.3. Global Mental Health Clinical Trials Market Estimates & Forecasts by Phase 2019-2029 (USD Billion)
• 6.4. Mental Health Clinical Trials Market, Sub Segment Analysis
  • 6.4.1. Phase I
  • 6.4.2. Phase II
  • 6.4.3. Phase III
  • 6.4.4. Phase IV

Chapter 7. Global Mental Health Clinical Trials Market, by Study Design

• 7.1. Market Snapshot
• 7.2. Global Mental Health Clinical Trials Market by Study Design, Performance - Potential Analysis
• 7.3. Global Mental Health Clinical Trials Market Estimates & Forecasts by Study Design 2019-2029 (USD Billion)
• 7.4. Mental Health Clinical Trials Market, Sub Segment Analysis
  • 7.4.1. Interventional
  • 7.4.2. Observational
  • 7.4.3. Expanded Access

Chapter 8. Global Mental Health Clinical Trials Market, by Sponsor

• 8.1. Market Snapshot
• 8.2. Global Mental Health Clinical Trials Market by Sponsor, Performance - Potential Analysis
• 8.3. Global Mental Health Clinical Trials Market Estimates & Forecasts by Sponsor 2019-2029 (USD Billion)
• 8.4. Mental Health Clinical Trials Market, Sub Segment Analysis
  • 8.4.1. Pharmaceutical & Biopharmaceutical Companies
  • 8.4.2. Government Agencies
  • 8.4.3. Others

Chapter 9. Global Mental Health Clinical Trials Market, by Disorder

• 9.1. Market Snapshot
• 9.2. Global Mental Health Clinical Trials Market by Disorder, Performance - Potential Analysis
• 9.3. Global Mental Health Clinical Trials Market Estimates & Forecasts by Disorder 2019-2029 (USD Billion)
• 9.4. Mental Health Clinical Trials Market, Sub Segment Analysis
  • 9.4.1. Anxiety Disorders
  • 9.4.2. Depression
  • 9.4.3. Bipolar affective disorder
  • 9.4.4. Dissociation and dissociative disorders
  • 9.4.5. Schizophrenia
  • 9.4.6. Others

Chapter 10. Global Mental Health Clinical Trials Market, Regional Analysis

• 10.1. Mental Health Clinical Trials Market, Regional Market Snapshot
• 10.2. North America Mental Health Clinical Trials Market
  • 10.2.1. U.S. Mental Health Clinical Trials Market
    • 10.2.1.1. Phase breakdown estimates & forecasts, 2019-2029
    • 10.2.1.2. Study Design breakdown estimates & forecasts, 2019-2029
    • 10.2.1.3. Sponsor breakdown estimates & forecasts, 2019-2029
    • 10.2.1.4. Disorder breakdown estimates & forecasts, 2019-2029
  • 10.2.2. Canada Mental Health Clinical Trials Market
• 10.3. Europe Mental Health Clinical Trials Market Snapshot
  • 10.3.1. U.K. Mental Health Clinical Trials Market
  • 10.3.2. Germany Mental Health Clinical Trials Market
  • 10.3.3. France Mental Health Clinical Trials Market
  • 10.3.4. Spain Mental Health Clinical Trials Market
  • 10.3.5. Italy Mental Health Clinical Trials Market
  • 10.3.6. Rest of Europe Mental Health Clinical Trials Market
• 10.4. Asia-Pacific Mental Health Clinical Trials Market Snapshot
  • 10.4.1. China Mental Health Clinical Trials Market
  • 10.4.2. India Mental Health Clinical Trials Market
  • 10.4.3. Japan Mental Health Clinical Trials Market
  • 10.4.4. Australia Mental Health Clinical Trials Market
  • 10.4.5. South Korea Mental Health Clinical Trials Market
  • 10.4.6. Rest of Asia Pacific Mental Health Clinical Trials Market
• 10.5. Latin America Mental Health Clinical Trials Market Snapshot
  • 10.5.1. Brazil Mental Health Clinical Trials Market
  • 10.5.2. Mexico Mental Health Clinical Trials Market
• 10.6. Rest of The World Mental Health Clinical Trials Market

Chapter 11. Competitive Intelligence

• 11.1. Top Market Strategies
• 11.2. Company Profiles
  • 11.2.1. ICON Plc.
    • 11.2.1.1. Key Information
    • 11.2.1.2. Overview
    • 11.2.1.3. Financial (Subject to Data Availability)
    • 11.2.1.4. Product Summary
    • 11.2.1.5. Recent Developments
  • 11.2.2. Eli Lilly and Company
  • 11.2.3. Caidya
  • 11.2.4. Syneous Health
  • 11.2.5. Novo Nordisk AS
  • 11.2.6. Pharmaceutical Product Development, LLC
  • 11.2.7. Parexel International Corporation
  • 11.2.8. Corcept Therapeutics Incorporated (Corcept)
  • 11.2.9. Labcorp Drug Development
  • 11.2.10. IQVIA, Inc.

Chapter 12. Research Process

• 12.1. Research Process
  • 12.1.1. Data Mining
  • 12.1.2. Analysis
  • 12.1.3. Market Estimation
  • 12.1.4. Validation
  • 12.1.5. Publishing
• 12.2. Research Attributes
• 12.3. Research Assumption